GeneMind Biosciences Company Limited announced that it has raised CNY 400,000,000 in a round of funding co-led by new investors, Guangzhou Kingmed Diagnostics Group Co., Ltd. and Shanghai Guoxin Investment Development Co. Ltd. on August 2, 2023. The transaction also included participation from new investors, Shenzhen High-Tech Investment Group Co., Ltd., Changzhou Shuangye Venture Capital, Hunan Caixin Capital Management Co., Ltd. and Guochuang Zhiyuan Private Equity Fund.